NEUROCRINE BIOSCIENCES INC Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Neurocrine Biosciences Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Neurocrine Biosciences Inc Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 220M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 220M 0 0% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 220M 0 0% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 220M 0 0% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 220M 0 0% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 220M 0 0% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 220M 0 0% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 220M 0 0% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 220M 0 0% Dec 31, 2022 10-K 2024-02-09
Q3 2022 220M 0 0% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 220M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 220M 0 0% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 220M 0 0% Dec 31, 2021 10-K 2023-02-09
Q3 2021 220M 0 0% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 220M 0 0% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 220M 0 0% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 220M 0 0% Dec 31, 2020 10-K 2022-02-11
Q3 2020 220M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 220M 0 0% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 220M 0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 220M 0 0% Dec 31, 2019 10-K 2021-02-05
Q3 2019 220M 0 0% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 220M 0 0% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 220M 0 0% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 220M 0 0% Dec 31, 2018 10-K 2020-02-07
Q3 2018 220M 0 0% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 220M 0 0% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 220M 0 0% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 220M 0 0% Dec 31, 2017 10-K 2019-02-08
Q3 2017 220M 0 0% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 220M 0 0% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 220M +110M +100% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 220M 0 0% Dec 31, 2016 10-K 2018-02-13
Q3 2016 220M +110M +100% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 220M +110M +100% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 110M 0 0% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 220M +110M +100% Dec 31, 2015 10-K 2017-02-14
Q3 2015 110M 0 0% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 110M 0 0% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 110M 0 0% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 110M 0 0% Dec 31, 2014 10-K 2016-02-11
Q3 2014 110M 0 0% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 110M 0 0% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 110M 0 0% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 110M 0 0% Dec 31, 2013 10-K 2015-02-09
Q3 2013 110M 0 0% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 110M 0 0% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 110M 0 0% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 110M 0 0% Dec 31, 2012 10-K 2014-02-11
Q3 2012 110M 0 0% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 110M 0 0% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 110M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 110M 0 0% Dec 31, 2011 10-K 2013-02-08
Q3 2011 110M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 110M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 110M Dec 31, 2010 10-K 2012-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.